6801 - 6810 of 8587 Results
Title
Year
- Novel Approach to Movement Disorder Society–Unified Parkinson's Disease Rating Scale Monitoring in Clinical Trials: Longitudinal Item Response Theory Models2021OPENTitle: Novel Approach to Movement Disorder Society–Unified Parkinson's Disease Rating Scale Monitoring in Clinical Trials: Longitudinal Item Response Theory ModelsJournal Name: Movement Disorders Clinical PracticePublisher: WileyVol: 8Issue #: 7Start Page: 1083End Page: 1091Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/mdc3.13311Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mdc3.13311Citation Count: 7
-
-
OPENTitle: Alzheimer's Disease Alters Oligodendrocytic Glycolytic and Ketolytic Gene ExpressionJournal Name: The FASEB JournalPublisher: WileyVol: 35Issue #: S1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1096/fasebj.2021.35.s1.02461Best OA location URL: https://digitalcommons.wustl.edu/context/oa_4/article/3325/viewcontent/Alzheimer_s___Dementia___2021___Saito___Alzheimer_s_disease_alters_oligodendrocytic_glycolytic_and_ketolytic_gene.pdfCitation Count: 2
-
OPENTitle: Thyroarytenoid Muscle Gene Expression in a Rat Model of Early‐Onset Parkinson's DiseaseJournal Name: The LaryngoscopePublisher: WileyVol: 131Issue #: 12Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/lary.29661Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/8595495Citation Count: 11
- A zebrafish screen reveals Renin-angiotensin system inhibitors as neuroprotective via mitochondrial restoration in dopamine neurons2021OPENTitle: A zebrafish screen reveals Renin-angiotensin system inhibitors as neuroprotective via mitochondrial restoration in dopamine neuronsJournal Name: eLifePublisher: eLife Sciences Publications, LtdVol: 10Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.7554/elife.69795Best OA location URL: https://cdn.elifesciences.org/articles/69795/elife-69795-v1.pdfCitation Count: 27
- Pharmacological rescue of impaired mitophagy in Parkinson’s disease-related LRRK2 G2019S knock-in mice2021OPENTitle: Pharmacological rescue of impaired mitophagy in Parkinson’s disease-related LRRK2 G2019S knock-in miceJournal Name: eLifePublisher: eLife Sciences Publications, LtdVol: 10Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.7554/elife.67604Best OA location URL: https://cdn.elifesciences.org/articles/67604/elife-67604-v1.pdfCitation Count: 113
-
OPENTitle: Focused WorkshopsJournal Name: European Journal of NeurologyPublisher: WileyVol: 28Issue #: S1Start Page: 23End Page: 43Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1111/ene.14970Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/ene.14970Citation Count: 0
-
OPENTitle: Investigating lymphocyte populations in patients with Parkinson’s diseaseJournal Name: Annals of Translational MedicinePublisher: AME Publishing CompanyVol: 8Issue #: 6Start Page: 276End Page: 276Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.21037/atm.2020.02.29Best OA location URL: https://atm.amegroups.com/article/viewFile/37712/pdfCitation Count: 3
- Patient and caregiver characteristics associated with caregiver burden in Parkinson’s disease: a palliative care approach2019OPENTitle: Patient and caregiver characteristics associated with caregiver burden in Parkinson’s disease: a palliative care approachJournal Name: Annals of Palliative MedicinePublisher: AME Publishing CompanyVol: 9Issue #: S1Start Page: S24End Page: S33Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.21037/apm.2019.10.01Best OA location URL: https://apm.amegroups.com/article/viewFile/31642/26522Citation Count: 130
- The recent failure of the PROMESA clinical trial for multiple system atrophy raises the question—are polyphenols a viable therapeutic option against proteinopathies?2020OPENTitle: The recent failure of the PROMESA clinical trial for multiple system atrophy raises the question—are polyphenols a viable therapeutic option against proteinopathies?Journal Name: Annals of Translational MedicinePublisher: AME Publishing CompanyVol: 8Issue #: 11Start Page: 719End Page: 719Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.21037/atm.2020.01.117Best OA location URL: https://atm.amegroups.com/article/viewFile/35635/pdfCitation Count: 7